| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.DLD.2014.02.010 |
| P698 | PubMed publication ID | 24631029 |
| P50 | author | Antonio Grieco | Q51119909 |
| Valerio Nobili | Q56507694 | ||
| Anna Alisi | Q42430617 | ||
| Luca Miele | Q49363519 | ||
| P2093 | author name string | Valentina Giorgio | |
| Francesca Ferretti | |||
| Maria Pia Villa | |||
| Luigi Principessa | |||
| Valentina Negro | |||
| P433 | issue | 6 | |
| P921 | main subject | liver disease | Q929737 |
| metabolic dysfunction–associated steatotic liver disease | Q1546498 | ||
| non-alcoholic fatty liver | Q66299798 | ||
| P304 | page(s) | 556-560 | |
| P577 | publication date | 2014-03-12 | |
| P1433 | published in | Digestive and Liver Disease | Q15766194 |
| P1476 | title | Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity | |
| P478 | volume | 46 |
| Q90163066 | Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD) |
| Q40371820 | Assessment of the Intestinal Barrier with Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice |
| Q47559184 | Association between obstructive sleep apnea and non-alcoholic fatty liver disease: a systematic review and meta-analysis |
| Q36023779 | Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease |
| Q52677079 | Characterizing the metabolic phenotype of intestinal villus blunting in Zambian children with severe acute malnutrition and persistent diarrhea. |
| Q92460951 | Circulating microbiota-derived metabolites: a "liquid biopsy? |
| Q30241940 | Developmental origins of NAFLD: a womb with a clue |
| Q39448627 | Docosahexaenoic acid and non-alcoholic fatty liver disease in obese children: a novel approach? |
| Q89464205 | Dysregulated FXR-FGF19 signaling and choline metabolism are associated with gut dysbiosis and hyperplasia in a novel pig model of pediatric NASH |
| Q35981027 | Endomicroscopic and Transcriptomic Analysis of Impaired Barrier Function and Malabsorption in Environmental Enteropathy |
| Q34330120 | Fructose induced endotoxemia in pediatric nonalcoholic Fatty liver disease |
| Q28083295 | Gut Microbiota and Host Reaction in Liver Diseases |
| Q55008998 | Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease. |
| Q38742769 | Gut Microbiota of Nonalcoholic Fatty Liver Disease |
| Q61807446 | Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease |
| Q34499017 | Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease |
| Q35685083 | Gut-liver axis, nutrition, and non-alcoholic fatty liver disease |
| Q30665173 | Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability |
| Q89878911 | Increased Colonic Permeability and Lifestyles as Contributing Factors to Obesity and Liver Steatosis |
| Q55252106 | Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? |
| Q34647607 | Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease |
| Q35629725 | Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease |
| Q38721837 | Innate Immunity and Inflammation in NAFLD/NASH. |
| Q64905805 | Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention. |
| Q60949906 | Intestinal Microbiota Modulation in Obesity-Related Non-alcoholic Fatty Liver Disease |
| Q28067113 | Intestinal permeability in a patient with liver cirrhosis |
| Q90205918 | Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation |
| Q37215934 | Non-alcoholic fatty liver and the gut microbiota |
| Q30241387 | Nonalcoholic Fatty Liver Disease: Pathophysiology and Management |
| Q48099354 | Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome. |
| Q62066868 | Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease |
| Q36148926 | Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota |
| Q37723991 | Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia |
| Q36546330 | Rapamycin preserves gut homeostasis during Drosophila aging |
| Q35921869 | Targeting Dysbiosis for the Treatment of Liver Disease |
| Q35759448 | Targeting gut-liver axis for the treatment of nonalcoholic steatohepatitis: translational and clinical evidence |
| Q52721472 | The Role of Intestinal C-type Regenerating Islet Derived-3 Lectins for Nonalcoholic Steatohepatitis. |
| Q58115572 | The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD |
| Q39398254 | The intestinal barrier: a fundamental role in health and disease |
| Q38789869 | The intestinal microbiome and paediatric liver disease |
| Q92460937 | The intestinal microbiota fuelling metabolic inflammation |
| Q41158897 | Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment. |
Search more.